静脉输血栓溶解后无法解释的早期神经病变的危险因素:一个元分析
1From The Neurology Department, Lianyungang Clinical College of Nanjing Medical University, Lianyungang, China.
Neurosciences (Riyadh, Saudi Arabia)
|April 8, 2025
概括
在急性缺血性中风 (AIS) 的静脉血栓溶解 (IVT) 后,无法解释的早期神经系统恶化 (END) 影响了12%的患者. 关键的危险因素包括人口统计,并发症如高血压和糖尿病,以及白细胞数量升高.
科学领域:
- 神经学 神经学
- 脑卒中医学 脑卒中医学
- 临床研究 临床研究
背景情况:
- 早期神经系统恶化 (END) 是急性缺血性中风 (AIS) 中静脉输血栓溶解 (IVT) 后的一个关键并发症.
- 确定END的风险因素对于改善患者的治疗结果和制定有针对性的干预措施至关重要.
研究的目的:
- 系统地识别和分析与AIS患者IVT后无法解释的END相关的风险因素.
- 探索潜在的机制,这些因素对终结症发病和进展的贡献的基础.
主要方法:
- 在PubMed,Web of Science和EMBASE数据库中按照PRISMA指南进行了系统的文献搜索.
- 一项元分析包括16项研究,研究了AIS患者的END,这些患者在症状出现后4.5小时内接受IVT治疗.
- 数据综合的重点是确定各种因素与IVT后END发病率之间的显著关联.
主要成果:
- 在接受IVT的AIS患者中,END的总发病率为12% (95%CI,10%-15%).
- 确定的重大危险因素包括晚年,男性性别,高血压,糖尿病,心房动,使用抗高血压药和抗血小板药,高血糖,白细胞数量升高,胆固醇水平,血压,治疗时间和大动脉动脉硬化 (LAA).
结论:
- 监测一系列因素,包括并发症和特定生物标志物,对于管理和潜在地预防END至关重要.
- 在AIS后的END中白细胞的作用需要进一步研究,以指导针对性预防疗法的开发.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
Disorders of Hemostasis
658
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
658


